Tanya Dorff
@TDorffOnc
Followers
2K
Following
1K
Statuses
1K
medical oncology, genitourinary cancers
Los Angeles, CA
Joined September 2017
RT @neerajaiims: Ab#66 @ASCO #GU25 by @DrRanaMcKay👉�Triplet Rx w/ darolutamide vs abiraterone in real-world in mHSPC…
0
20
0
RT @drenriquegrande: At @asco #GU25 we will see the 29.1 months median follow-up updated data from EV302!!!! 30.4% of pts in the EV+P arm…
0
26
0
RT @pcan_journal: 🎙️ New Podcast Alert! 🚀 Don’t miss our exclusive 2025 interview with the Editor-in-Chief of Prostate Cancer and Prostatic…
0
3
0
RT @OncHahn: MultiD discussion on mgmt of localized HRPCa and N+ prostate cancer by @drjefstathiou @jdhdavis Dr. Keyes with great insights…
0
4
0
RT @WalterStadler5: Incredibly honored. Looking forward to extending world class care and research closer to where patients live.
0
3
0
RT @OncHahn: Provocative discussion on current and upcoming treatments for metastatic prostate cancer by @TDorffOnc Dr. Petrylak and Dr. Sa…
0
2
0
RT @Uromigos: THANK YOU for your support and over 400,000 listens! ASCO GU podcasts: 🥸Prostate- TALAPRO @neerajaiims, ARPI discussion @TD…
0
12
0
RT @OncHahn: I'll be speaking at the 35th International Prostate Cancer Update conference in Vail, CO, on February 9-12. Join or register…
0
11
0
RT @neerajaiims: Ab#310 @ASCO #GU25 by #AbdenourNabid👉�22 years of f/u on testosterone (T) recovery in pts w/ #pros…
0
17
0
RT @neerajaiims: Ab#312 @ASCO #GU25 by #WilliamAronson👉�CAPFISH-3 ph2 trial👉high omega-3, low omega-6 diet in #prost…
0
9
0
RT @tompowles1: TROPICS4 sacituzimab govitecan vs chemo in pretreated UC @Annals_Oncology OS & PFS HRs=0.86. RR 23 vs 14, but G3+ TRAE 67 v…
0
31
0
RT @charlesryanmd: Did you know there are 4.75 Million Americans alive today due to progress against cancer? Check out our (w @CaPsurvivors…
0
7
0
RT @montypal: Thanks @TDorffOnc for hosting an awesome @OncLiveSOSS in #Anaheim, kicking off with awesome talks from our @cityofhopeoc star…
0
17
0
RT @nsayeghmd: Honored to receive the Merit Award at #GU25 for our exploratory analysis of the @SWOG 1216 trial⭐️ Grateful for the mentorsh…
0
6
0
@QMBCI @TimGilliganMD @tompowles1 @QMULBartsTheLon @NHSBartsHealth @QMUL @CRUKCOLcentre Congratulations! Your work has been hugely impactful to patients and physician scientists.
0
0
1
RT @TiansterZhang: Check out our latest paper on circulating immune biomarkers for metastatic #kidneycancer! While immunotherapy combos ha…
0
23
0
RT @DrRanaMcKay: Getting ready to kick off the third annual Prostate Cancer Patient Summit hosted by @UCSDCancer and @PCFnews. A great…
0
8
0
RT @SFreedlandMD: Interested in #ProstateCancer? 2-yr T32 Prostate Cancer Training Program at Cedars-Sinai starting Summer 2025! Open posit…
0
15
0
RT @pcan_journal: 🎉✨ Happy New Year! ✨🎉 A heartfelt thank you to our amazing authors, dedicated readers, brilliant editors, and tireless r…
0
5
0
@montypal @cityofhope @ClaytonLauMD @Kanurkkoooo @WesleyYipMD @arafflemd @DrRaviSalgia @DrMvandenBrink @stacywgray @leowanglab @kortylmt @ReginaBarCar @NazliDizman @SalvadorjcMD So happy to work with this phenomenal GU team! ❤️
0
1
7